IN THE NEWS

Healthcare M&A Advisory Firm Welcomes New Leadership Team

Published July 12th 2022 Originally Published by Cision PR Newswire July 12th 2022

FORT WORTH, Texas, July 12, 2022 /PRNewswire/ -- VERTESS, a leading healthcare mergers and acquisitions (M&A) advisory firm, is pleased to announce the addition of three new Partners. Managing Directors Rachel Boynton, Anna Elliott, and Robert Villalobos are the newest additions to the leadership team. All three bring a wealth of knowledge and experience to the team and will help shape the growing enterprise with their guidance and expertise.

Rachel Boynton joined VERTESS in 2018 as a Managing Director and has proven to be a successful, dedicated, and compassionate team member. Prior to joining VERTESS, she co-founded a multi-state human services and healthcare organization where she oversaw the operations, finance, human resources, and quality insurance departments. At VERTESS, she provides M&A advisory and consulting services to the intellectual and developmental disability (I/DD), behavioral health, and related healthcare markets. "As a former healthcare business owner, I know how dedicated the leadership team needs to be to run a successful company," Rachel noted. "I am excited to further support the VERTESS team as a Partner."

Anna Elliott is the most recent addition to the VERTESS team of the new Partners, having joined earlier this year. Prior to her Managing Director role with VERTESS, she co-founded a boutique M&A firm in Pennsylvania, where she developed her passion for mergers and acquisitions. She brings over 15 years of experience working in high-growth, healthcare technologies with specific experience in Deep Tech, SAAS, Artificial Intelligence, Machine Learning, Ambient Solutions, and healthcare companies. She is eager to continue her work and further expand her footprint in the healthcare industry as a Partner at VERTESS. "Although I am new to the VERTESS team, I have been wowed by the entire team's professionalism and attention to detail," Anna stated. "I am looking forward to many years of success!"

Robert Villalobos began his tenure at VERTESS in 2016 as a Business Development leader. Prior to VERTESS, he worked in public relations and marketing in various industries and facilitated the operation of a non-profit business incubator for entrepreneurs and small business owners. In his role as Director of Business Development, he sourced and cultivated leads for Managing Directors. He transitioned into the role of Managing Director and Partner earlier this year after demonstrating a natural ability and keen proficiency with the transaction process by closing several transactions while still in the Business Development role. "Becoming a Partner was important to me because it gives me a stake in the success of our firm," Rob commented. "It continues to help motivate me personally to drive value for VERTESS as a whole."

For more information, please contact Vaughne Glennie, Director of Marketing + Operations/Partner, Rachel Boynton, Anna Elliott, or Robert Villalobos at +1-520-395-0244 or [email protected]

Continue Reading

MORE NEWS

VERTESS Answers: Why Do I Need to Market My Company to Buyers?

If you own a healthcare company, you are probably receiving inquiries from interested buyers. We view this as buyers mar...
Read More

6 Recommendations To Run a Better ASC and Achieve a Successful Sale

Preparing an ambulatory surgery center (ASC) for a sale is a worthwhile process for center owners regardless of whether ...
Read More

Hospital at Home: A Shift in the Healthcare System

We're seeing a notable shift occurring in healthcare. While we have largely focused on how to enhance care delivery with...
Read More

VERTESS Answers: Should I Work With a Healthcare Advisor or Broker?

We will occasionally hear from the owner of a healthcare company something along the lines of the following: "I know som...
Read More

Parallels Between Early Clinical and Early Transaction Intervention

My educational and professional experiences have demonstrated to me the importance and value of early intervention, both...
Read More

Corporate Transparency Act: What It Is and What You Need To Do

The Corporate Transparency Act (CTA) went into effect on Jan. 1, 2024. This federal reporting requirement affects millio...
Read More

Are You Ready to Sell Your Healthcare Company?

After spending many years building your healthcare company, it's increasingly likely that you will find yourself thinkin...
Read More

Healthcare M+A in 2024: What to Expect

As VERTESS celebrates its 10th Anniversary - 2014 seems like only yesterday to most of us! - we are reflecting on the jo...
Read More

Element RCM: Selling Your ABA Practice Tips

Rachel is unique as a Mergers & Acquisitions (M&A) Adviser: she owned and operated Lifeshare, an IDD services bu...
Read More

VERTESS Triumphs: 4 Deals Closed in Q2

FORT WORTH, Texas, Sept. 18, 2020 /PRNewswire/ VERTESS (www.vertess.com), a leading healthcare mergers and acquisitions ...
Read More
1 2 3 22

COMMITTED TO CONSTANT IMPROVEMENT?

Want to stay current with trends in the medical/healthcare space as well as receive expert advice of veteran medical entrepreneurs?
SUBSCRIBE TO OUR BI-WEEKLY NEWSLETTER VERTESSPRESS
For over 10 years, we've been teaching ways you can improve the value of your healthcare company, focusing on informing you about mergers + acquisitions, including M+A trends in the healthcare market.
CHECK OUT VERTESSPRESS THE BLOG
No Spam Ever. We Promise
©2024 VERTESS. All Rights Reserved.